Zynerba Prescription drugs (ZYNE) closed at $4.15 within the newest buying and selling session, marking a +1.47% transfer from the prior day. This alteration lagged the S&P 500’s 1.95% achieve on the day. Elsewhere, the Dow gained 1.85%, whereas the tech-heavy Nasdaq added 1.55%. www.nasdaq.com
Zynerba Prescription drugs (ZYNE) closed at $4.15 within the newest buying and selling session, marking a +1.47% transfer from the prior day. This alteration lagged the S&P 500’s 1.95% achieve on the day. Elsewhere, the Dow gained 1.85%, whereas the tech-heavy Nasdaq added 1.55%.
www.nasdaq.com